Beaver-Visitec said today it acquired ophthalmic tech company Vitreq for an undisclosed amount.
Netherlands-based Vitreq develops and manufactures ophthalmic devices, with a specific focus on vitreoretinal surgery. The company’s portfolio includes a number of minimally-invasive instruments designed for use in ophthalmological surgical settings, Waltham, Mass.-based Beaver-Visitec said.
“At Vitreq, it’s our mission to develop reliable, safe, and sophisticated tools that provide surgeons with the support and innovation necessary to perform at the highest levels. In BVI, we have found a partner that is committed to growing our organization, best positioning us to achieve our mission of becoming one of the leading vitreoretinal surgery platforms. The company continues to build a robust, high-quality ophthalmic portfolio that we are thrilled to become a part of. We look forward to working closely with Dana and the rest of the team to expand our product offering and footprint,” co-founder & CEO Frank Ruseler said in a prepared statement.
“The Vitreq team has quickly established a trusted brand with vitreoretinal surgeons through their unique, customer-centric product development model. We are excited to combine our efforts with the goal of building a leading global vitreoretinal franchise under the Vitreq brand. We welcome the Vitreq employees to the BVI team and look forward to delivering our combined portfolio of high quality, innovative products to an expanded group of customers worldwide,” BVI CEO Dana Mead Jr. said in a press release.
The acquisition comes hot on the heels of Beaver-Visitec’s purchase of Malosa Medical, which it acquired in April for an undisclosed amount.
Malosa Medical had a portfolio of more than 400 products, according to Beaver-Visitec. Malosa packages its sets in sterilized, single-use packs which contain all required instruments and consumables for specific ophthalmic procedures, including cataract surgery and intravitreal injections, BVI added.
